Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice

被引：0
|
作者：
Agca, Rabia [1 ]
Smulders, Yvo [2 ]
Nurmohamed, Michael [1 ]
机构：
[1] Amsterdam UMC & Reade, Rheumatol, Amsterdam, Noord Holland, Netherlands
[2] Amsterdam UMC, Internal Med, Amsterdam, Noord Holland, Netherlands
来源：
HEART | 2022年 / 108卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：73 / 79
页数：7
相关论文
共 50 条
  • [1] Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice
    Agca, Rabia
    Smulders, Yvo
    Nurmohamed, Michael
    [J]. HEART, 2022, 108 (07) : 73 - 79
  • [2] Association between chronic immune-mediated inflammatory diseases and cardiovascular risk
    Miguel Baena-Diez, Jose
    Garcia-Gil, Maria
    Comas-Cufi, Marc
    Ramos, Rafel
    Prieto-Alhambra, Daniel
    Salvador-Gonzalez, Betlem
    Elosua, Roberto
    Degano, Irene R.
    Penafiel, Judith
    Grau, Maria
    [J]. HEART, 2018, 104 (02) : 119 - 126
  • [3] The Biologics in Clinical Practice: A Modern Approach for Inflammatory and Immune-Mediated Diseases
    Offidani, A.
    Campanati, A.
    [J]. CURRENT DRUG SAFETY, 2016, 11 (01) : 3 - 3
  • [4] Cardiovascular effects of methotrexate in immune-mediated inflammatory diseases
    Balanescu, Andra-Rodica
    Bojinca, Violeta Claudia
    Bojinca, Mihai
    Donisan, Teodora
    Balanescu, Serban Mihai
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (02) : 1024 - 1029
  • [5] Management of cardiovascular comorbidities in immune-mediated inflammatory diseases
    Roubille, C.
    [J]. REVUE DE MEDECINE INTERNE, 2024, 45 (04): : 194 - 199
  • [6] Management of cardiovascular comorbidities in immune-mediated inflammatory diseases
    Roubille, C.
    [J]. REVUE DE MEDECINE INTERNE, 2022, 43 : A299 - A303
  • [7] Glucocorticoids in patients with immune-mediated inflammatory diseases: a neglected cardiovascular risk factor
    Galiuto, Leonarda
    Volpe, Massimo
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (13) : 1197 - 1198
  • [8] Use of coronarycomputed tomography for cardiovascular risk assessment in immune-mediated inflammatory diseases
    Peverelli, Marta
    Maughan, Robert T.
    Gopalan, Deepa
    Dweck, Marc R.
    Dey, Damini
    Buch, Maya H.
    Rudd, James H. F.
    Tarkin, Jason M.
    [J]. HEART, 2024, 110 (08) : 545 - 551
  • [9] Cardiovascular Disease in Immune-Mediated Inflammatory Diseases: Cross Sectional Analysis of the Influence of Demographic and Traditional Cardiovascular Risk Factors
    Rodriguez-Rodriguez, Luis
    Perrotti, Pedro P.
    Aterido, Adria
    Tornero, Jesus
    Ferrandiz, Carlos
    Canete, Juan D.
    Fernandez-Nebro, Antonio
    Gisbert, Javier P.
    Domenech, Eugeni
    Lopez-Lasanta, Maria
    Marsal, Sara
    Fernandez-Gutierrez, Benjamin
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [10] Cancer risk in immune-mediated inflammatory diseases (IMID)
    Beyaert, Rudi
    Beaugerie, Laurent
    Van Assche, Gert
    Brochez, Lieve
    Renauld, Jean-Christophe
    Viguier, Manuelle
    Cocquyt, Veronique
    Jerusalem, Guy
    Machiels, Jean-Pascal
    Prenen, Hans
    Masson, Pierre
    Louis, Edouard
    De Keyser, Filip
    [J]. MOLECULAR CANCER, 2013, 12
12345